ChemCo Tirzepatide 40mg Pen – High-Purity Research Compound

The ChemCo Tirzepatide 40mg Pen delivers a pre-formulated, analytical-grade presentation of Tirzepatide (LY3298176) engineered for dual-receptor binding assays, incretin signaling kinetics, insulinotropic response models, and glycemic regulation studies. Containing 40mg of total active multi-functional synthetic peptide, this pre-filled dialable pen format eliminates manual reconstitution errors and provides reliable volumetric precision across longitudinal laboratory trials.

Technical Specifications & Chemical Profile

• Product Identifier: ChemCo Tirzepatide 40mg Pen

• Active Compound: Tirzepatide (LY3298176)

• Total Concentration: 40mg per pen unit

• Chemical Class: Synthetic Dual GIP / GLP-1 Receptor Agonist

• CAS Registry Number: 2023788-19-2

• Molecular Formula: $C_{225}H_{348}N_{48}O_{68}$

• Molecular Weight: 4813.45 g/mol

• Structural Design: 39-amino-acid peptide backbone conjugated with a $C_{20}$ fatty diacid moiety

• Purity Threshold: ≥98% (HPLC & LC-MS Verified)

• Delivery Format: Precision Dialable Multi-Dose Pen Presentation

Compare dual-agonist mechanisms with our novel triple-agonist series such as the ChemCo Retatrutide 60mg Pen or return to the main ChemCo Peptides Hub.

Technical Advantages of the Tirzepatide 40mg Pen Presentation

Selecting a pre-filled tirzepatide 40mg pen UK inventory unit provides key operational and procedural advantages for scientific study:

1. High Total Active Yield: The 40mg total volume supports multi-stage titration and high-throughput cell assay models without batch-to-batch variation.

2. Elimination of Lyophilized Reconstitution: Pre-mixed liquid matrix avoids fluid volume miscalculations, solubility degradation, or equipment contamination.

3. Calibrated Dialing Wheel: Mechanical step-wise adjustment ring permits exact micro-litre sample administration across multi-specimen testing protocols.

Dual Agonist Mechanism of Action & Research Applications

When evaluating chemco tirzepatide research pen samples, researchers study a dual-acting peptide designed to engage two key incretin receptor pathways:

                          ┌──> GIP Receptor (Nutrient Sensing & Lipolysis Dynamics)
                          │
ChemCo Tirzepatide 40mg ──┼──> GLP-1 Receptor (Glucose-Dependent Insulin Secretion)
(LY3298176)               │
                          └──> Synergistic Intracellular cAMP Signal Transduction

1. Glucose-Dependent Insulinotropic Polypeptide (GIP) Agonism

Tirzepatide displays high affinity for the GIP receptor, serving as a primary tool to evaluate GIP-mediated glucagon regulation, lipid deposition, and metabolic insulin sensitivity.

2. Glucagon-Like Peptide-1 (GLP-1) Agonism

Engages GLP-1 receptors to stimulate cAMP accumulation and glucose-dependent insulin release in pancreatic beta-cell models.

3. Synergistic Incretin Receptor Dynamics

Enables comparative benchmark evaluation against single-agonist reference standards (e.g., Semaglutide) to quantify dual-receptor signaling co-action.

Quality Control & Analytical Batch Testing

Every tirzepatide 40mg pen distributed by ChemCo Medical is backed by lot-specific, verifiable analytical documentation:

• High-Performance Liquid Chromatography (HPLC): Guarantees active sequence purity meets or exceeds 98%, ruling out baseline peptide fragments or acylation degradation.

• Liquid Chromatography-Mass Spectrometry (LC-MS): Verifies exact 4813.45 Da molecular weight and correct primary amino acid sequence.

• Cold-Chain Maintenance: Handled and shipped under refrigerated conditions to preserve structural stability prior to laboratory use.

Storage & Handling Guidelines

• Unopened Unit: Refrigerate between 2°C and 8°C inside original packaging to shield solution from UV exposure.

• In-Use Storage: Return unit to cold storage (2°C–8°C) immediately following sample withdrawal.

• Thermal Notice: Do not freeze pre-filled liquid pen cartridges to prevent mechanical ring damage or peptide denaturation.

Mandatory Research Compliance Notice

• Strictly for Laboratory and Scientific Research Only: The ChemCo Tirzepatide 40mg Pen is supplied strictly for in vitro laboratory research, analytical testing, and scientific study.

• Not for Human or Veterinary Administration: This product is explicitly prohibited from being used as a drug, human weight-loss product, therapeutic substance, or medical device.